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Abstract Purpose: Septic shock
has been associated with microvas-
cular alterations and these in turn
with the development of organ dys-
function. Despite advances in video
microscopic techniques, evaluation of
microcirculation at the bedside is still
limited. Venous-to-arterial carbon
dioxide difference (Pv-aCO2) may be
increased even when venous O2 sat-
uration (SvO2) and cardiac output
look normal, which could suggests
microvascular derangements. We
sought to evaluate whether Pv-aCO2
can reflect the adequacy of
microvascular perfusion during the
early stages of resuscitation of septic
shock. Methods: Prospective obser-
vational study including 75 patients
with septic shock in a 60-bed mixed
ICU. Arterial and mixed-venous
blood gases and hemodynamic vari-
ables were obtained at catheter
insertion (T0) and 6 h after (T6).
Using a sidestream dark-field device,
we simultaneously acquired sublin-
gual microcirculatory images for
blinded semiquantitative analysis. Pv-
aCO2 was defined as the difference
between mixed-venous and arterial
CO2 partial pressures. Results: Pro-
gressively lower percentages of small
perfused vessels (PPV), lower func-
tional capillary density, and higher
heterogeneity of microvascular blood
flow were observed at higher Pv-
aCO2 values at both T0 and T6. Pv-
aCO2 was significantly correlated to
PPV (T0: coefficient -5.35, 95 % CI
-6.41 to -4.29, p\ 0.001; T6:
coefficient, -3.49, 95 % CI -4.43 to
-2.55, p\ 0.001) and changes in Pv-
aCO2 between T0 and T6 were sig-
nificantly related to changes in PPV
(R2 = 0.42, p\ 0.001). Absolute
values and changes in Pv-aCO2 were
not related to global hemodynamic
variables. Good agreement between
venous-to-arterial CO2 and PPV was
maintained even after corrections for
the Haldane effect. Conclu-
sions: During early phases of
resuscitation of septic shock, Pv-
aCO2 could reflect the adequacy of
microvascular blood flow.
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Introduction
Septic shock remains associated with high mortality and
early recognition of signs of tissue hypoperfusion is cru-
cial in its management [1, 2]. The usefulness of oxygen-
derived parameters as resuscitation targets has been
strongly questioned [3] and recent data have failed to
demonstrate clinical benefits [4–6]. Indeed, venous oxy-
gen saturation (SvO2) is often normal or near normal at
admission to ICU [7]. Hence, other resuscitation goals
such as venous-to-arterial carbon dioxide difference (Pv-
aCO2) have been proposed owing to their simplicity and
ability to predict adverse clinical outcomes in patients
achieving normal oxygen-derived parameters during the
early phases of resuscitation of septic shock [8–10].
Nevertheless, the mechanisms implicated in the elevation
of Pv-aCO2 during inflammatory states are not completely
understood and interpretation of Pv-aCO2 values during
resuscitation of septic shock could sometimes be difficult.
In cardiac arrest Pv-aCO2 increases as a result of
vascular stagnation [11, 12]. Similarly, Pv-aCO2 and
cardiac output are inversely related in experimental
models of hemorrhagic, hypovolemic, and obstructive
shock, highlighting the importance of blood flow in
increasing venous CO2 [13–16]. Conversely, agreement
between cardiac output variations and Pv-aCO2 during
septic shock is weak [17, 18], suggesting that macrohe-
modynamic alterations cannot explain such Pv-aCO2
variations [8, 9]. Alternatively, Pv-aCO2 could be related
to tissue oxygenation derangements or oxygen consump-
tion capabilities [13, 14], but this concept was questioned
when others demonstrated that ischemic but not hypoxic
or anemic hypoxia leads to Pv-aCO2 increments [19, 20].
Hence, physiological variables different to macrohemo-
dynamics and tissue dysoxia should be associated with
variations of Pv-aCO2 gradients during septic shock.
Microcirculatory derangements such as decreases in
functional capillary density (FCD) and increased hetero-
geneity of blood flow are common findings in patients
with severe sepsis and septic shock [21, 22], even when
global oxygen parameters seem adequate. Importantly,
these abnormalities might be associated with the devel-
opment of multiple organ dysfunction and death [23].
Nevertheless, despite improvements in techniques evalu-
ating microcirculation at the bedside, immediate and
reliable quantification of microcirculatory derangements
is still limited. Thus, surrogates reflecting adequacy of
microvascular blood flow might be highly valuable.
Tissue CO2 accumulation has been related to micro-
circulatory alterations [24, 25]. However, the relationship
between Pv-aCO2 and microcirculatory derangements
during human septic shock has not been widely studied.
Since Pv-aCO2 has been related to blood flow variations,
but cardiac output seems insufficient to explain venous
CO2 accumulation during septic shock [8, 9], we aimed to
test the hypothesis that Pv-aCO2 can reflect the adequacy
of microvascular blood flow during the early stages of
resuscitation in patients with septic shock.
Materials and methods
This prospective observational study was conducted in a
60-bed mixed ICU at a university hospital (Fundacio´n
Valle del Lili, Cali, Colombia) during 15 consecutive
months (April 2012 to July 2013). We received approval
from the Fundacio´n Valle del Lili’s ethical and biomed-
ical research committee (protocol number 563, approval
number 091-2012). The original version of the protocol is
attached as Electronic Supplementary Material 2 (ESM 2).
Written informed consent was waived as no new or inva-
sive procedures were conducted for the study purposes.
However, in all cases the patients and/or their relatives
were informed about the study and were given the oppor-
tunity to refuse the use of their data. Infection was defined
according to the Centers for Diseases Control and
Prevention criteria [26], whereas septic shock followed the
criteria of the American College of Chest Physicians/So-
ciety of Critical Care Medicine Consensus Conference
[27]. All consecutive patients fulfilling diagnostic criteria
of septic shock and elected by the attending physician to
use a pulmonary artery catheter (PAC) within the 6 h from
the first hypotensive episode were included in the study.
The decision to use a PAC was exclusively taken by the
attending physician according to the local protocols for
hemodynamic monitoring. We did not include patients
with a preceding episode of septic shock within the last
3 months, patients younger than 18 years old, pregnant
women, patients with limitation of therapeutic effort
orders, or severe chronic obstructive pulmonary disease.
Patients using cardiac output monitoring systems other
than PAC were not included. For assessment of microcir-
culation, we did not include patients who were under
noninvasive mechanical ventilation or breathing with a
face mask with high FiO2, or patients who were agitated or
not collaborative when we first attempted to visualize
sublingual microcirculation.
A STROBE statement checklist for observational
studies is provided in ESM Table E4.
General management
Patients were managed according to an early resuscitation
protocol modified from the Surviving Sepsis Campaign
[28], with the aim of achieving (1) mean arterial pressure
C65 mmHg; (2) urine output C0.5 ml/kg/min; (3) SvO2
C65 %; (4) normalization of lactate levels. Repeated fluid
loads with crystalloids and/or albumin 4 % guided by
212
dynamic predictors of fluid responsiveness were per-
formed in order to optimize cardiac preload. Dynamic
predictors of fluid response were preferred over static
parameters (i.e., pulmonary artery occlusion pressure or
central venous pressure). However, when the use of
dynamic predictors was not appropriate, cardiac filling
pressures and clinical judgment were used to guide fluid
administration. We did not use hydroxyethyl starches
(HES). Norepinephrine was titrated to maintain mean
arterial pressure (MAP) [65 mmHg. Low doses of
vasopressin titrated up to maximum of 0.03 IU/min were
allowed to increase MAP or to decrease norepinephrine
requirements but never as a single vasopressor. Dobu-
tamine was titrated up to 20 lg/kg/min when SvO2 goals
were not achieved after fluid load optimization and nor-
malization of MAP. Mechanical ventilation support was
provided when needed under a targeted sedation and
analgesia protocol with midazolam and fentanyl
Table 1 General characteristics
All patients
(n = 75)
Pv-aCO2\6.0
(n = 39)
Pv-aCO2 = 6.0–9.9
(n = 25)
Pv-aCO2 C10.0
(n = 11)
p
Age (years) 67 (58–77) 66 (60–74) 73 (65–81) 54 (43–71)* 0.02
Male (%) 45 (60) 23 (59) 15 (60) 7 (64) 0.96
APACHE II 25 (20–32) 24 (20–28) 28 (20–34) 25 (20–34) 0.55
SOFA, day 1 11 (8–15) 10 (6–15) 11 (9–15) 11 (10–14) 0.22
Time from first hypotension episode to
catheter insertion (h)
3 (3–4) 3 (3–4) 4 (2–4) 3 (2–4) 0.69
Fluids before catheter insertion (ml) 1650 (1200–2400) 1600 (1200–2400) 1600 (1025–2300) 2000 (1500–2700) 0.66
Temperature (C) 37.5 (37.4–38.4) 37.4 (37.2–38.2) 37.8 (37.6–38.4) 37.6 (37.5–38.6) 0.54
Source of infection, n (%) 0.25
Pneumonia 30 (40.0) 18 (46.2) 10 (40.0) 2 (18.2)
Abdominal 17 (22.7) 8 (20.5) 7 (28.0) 2 (18.2)
Urinary 10 (13.3) 4 (10.3) 3 (12.0) 3 (27.3)
Soft tissue 2 (2.7) 2 (5.1) 0 (0.0) 0 (0.0)
No specific site 7 (9.3) 1 (2.6) 3 (12.0) 3 (27.3)
Other 9 (12.0) 6 (15.4) 2 (8.0) 1 (9.1)
Medical, n (%)/surgical, n (%) 48 (64.0)/27 (36.0) 25 (64.1)/14 (35.9) 15 (60.0)/10 (40.0) 8 (72.7)/3 (27.3) 0.76
Mechanical ventilation, n (%) 57 (76.0) 34 (87.2) 24 (96.0) 9 (81.8) 0.37
Renal replacement therapy, n (%) 12 (16.0) 7 (17.9) 3 (12.0) 2 (18.2) 0.80
Values represent median (25–75th range) or absolute number (%) when indicated
* p\ 0.05 for Pv-aCO2 C10.0 vs. Pv-aCO2 = 6.0–9.9
Table 2 Microcirculatory blood flow variables for the predefined Pv-aCO2 groups
Pv-aCO2\6.0
(nT0 = 39) (nT6 = 36)
Pv-aCO2 = 6.0–9.9
(nT0 = 25) (nT6 = 23)
Pv-aCO2 C10.0
(nT0 = 11) (nT6 = 13)
PPV, %
T0 83.9 (74.2–93.2)* 56.8 (47.9–62.9) 40.1 (27.5–48.7)
T6 85.5 (77.8–92.3)* 61.7 (54.5–74.5) 43.2 (33.7–49.6)
LPV, %
T0 100 (97.0–100)* 96.0 (91.2–100) 90.0 (80.0–100)
T6 100 (96.0–100) 96.4 (91.7–100) 92.5 (72.3–98.8)
MFI
T0 2.4 (2.1–2.9)* 1.6 (1.2–1.9) 1.4 (1.1–1.9)
T6 2.4 (1.8–2.8)* 1.9 (1.4–2.3) 1.3 (1.0–1.7)
TCD, n/mm2
T0 11.5 (10.3–12.5) 10.8 (10.4–11.4) 10.2 (9.3–11.3)
T6 11.5 (10.3–13.3)* 10.1 (8.9–10.8) 10.8 (9.8–11.6)
FCD, n/mm2
T0 7.8 (6.2–9.6)* 4.9 (4.4–5.9) 3.4 (1.4–4.9)
T6 8.2 (7.2–10.2)* 5.4 (4.2–6.2) 4.7 (3.2–5.6)
Heterogeneity index
T0 0.24 (0.10–0.51)* 0.46 (0.33–0.63) 0.57 (0.29–1.04)
T6 0.15 (0.11–0.28)* 0.52 (0.21–0.84) 0.54 (0.37–0.80)
PPV percentage of small perfused vessels, LPV percentage of large
perfused vessels, MFI microvascular flow index, TCD total capil-
lary density, FCD functional capillary density
* p\ 0.05 Pv-aCO2\6.0 vs. Pv-aCO2 = 6.0–9.9
 p\ 0.05 Pv-aCO2\6.0 vs. Pv-aCO2 C10.0
 p\ 0.05 Pv-aCO2 = 6.0–9.9 vs. Pv-aCO2 C10.0
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according to the local procedures. Use of low dose
hydrocortisone (up to 200 mg/day) was indicated in the
case of persistence of vasopressor requirement despite
ensuring an adequate intravascular volume. Glycemic
control, venous thrombosis prophylaxis, and gastric ulcer
stress prevention were provided according to Surviving
Sepsis Guidelines [28].
Study protocol
All potentially eligible patients from the emergency room
or clinical/surgical wards were screened by our ‘‘rapid
response team’’ (which was available 24/7) and promptly
transferred to the ICU where attending physicians decided
on the type of hemodynamic monitoring needed. Those
equipped with PAC monitoring were consecutively
selected for inclusion. Time 0 (T0) was set when the PAC
was inserted. Arterial and mixed venous blood samples
were drawn for gases analysis (ABL300, Radiometer;
Copenhagen, Denmark) at T0 and 6 h after (T6). We
defined Pv-aCO2 as the difference between mixed-venous
and arterial CO2 partial pressures. Complete hemody-
namic and respiratory parameters, inotropic/vasopressor
doses, and volume of resuscitation fluids were also reg-
istered at these points. Simultaneously, sublingual
microcirculation images were also recorded and stored
under a random number for ulterior analysis [29].
Microcirculatory measurements
We used a sidestream dark-field (SDF) imaging device
(MicroScan; MicroVision Medical, Amsterdam, the
Netherlands) to explore microcirculation at T0 and T6.
The SDF device was softly applied to the lateral side of
the tongue covering an area of approximately 2.5–4 cm
from the tip of tongue after gentle removal of secretions
with gauze. At each measurement time, we recorded five
sequences of video of 20 s each from different adjacent
mucosa areas using a video card (Micro Video; Pinnacle
system, Mountain Views, CA, USA). These sequences of
video were stored under a random number and later
analyzed by two investigators blinded to the origin of
sequences (J.D.V. and G.O.T.). Vessels were classified as
large or small using a cutoff value of 20 lm. Microves-
sels with continuous flow were considered as normal,
whereas sluggish, intermittent, and stopped flows were
considered as abnormal. In accordance with the consensus
for the evaluation of microcirculation [29], we calculated
the proportion of small perfused vessels (\20 lm diam-
eter), the microvascular flow index (MFI), the
heterogeneity index (HI), the total vascular density (all
vessels), and the FCD (vessels\20 lm diameter). The
intra- and interobserver variability were determined by
using five sequences analyzed five times at 8-week
intervals by two observers (J.D.V. and G.O.T.). We cal-
culated the intra- and interobserver coefficient of
variability for both the total number of vessels and the
proportion of perfused vessels. An expanded description
of image acquisition and analysis is provided in the ESM.
Outcome measures
The primary outcome was the agreement between Pv-
aCO2 and PPV at T0 and T6. Secondary outcomes
included the relationships between Pv-aCO2 and hemo-
dynamic systemic variables, and the relationships
between changes in Pv-aCO2 and changes in cardiac
output and PPV observed between T0 and T6.
Statistics
As the primary hypothesis has not been tested before, it
was difficult to compute a sample size. On the basis of
previous data from our department [8], we estimated that
75 patients would provide a good range of dispersion of
Pv-aCO2 and PPV for looking at relationship between
variables.
Distribution of data was tested using the Kolmogorov–
Smirnoff test. We explored the relationship between
microcirculatory and systemic hemodynamic variables
using the Spearman rho test and calculating the coeffi-
cient of determination (R2) to establish the strength of
such associations. The distribution of microcirculatory
variables, systemic hemodynamics, blood gases, and
oxygen/tissue perfusion parameters at T0 and T6 was also
evaluated for three predefined groups classified according
to the Pv-aCO2 range values in agreement with previous
observations [8]: (1)\6.0 mmHg (2) 6.0–9.9 mmHg, and
(3) C10 mmHg. Differences among groups were assessed
using the Kruskal–Wallis test with post hoc Mann–
Whitney analysis with adjustment for multiple
comparisons.
We calculated the delta of variation of Pv-aCO2, PPV,
and cardiac outputs between T0 and T6. Spearman rho
test and R2 were used to evaluate the agreement and
Fig. 1 Percentage of small vessels perfused (PPV), functional
capillary density (FCD), and heterogeneity index (HI) for the
predefined Pv-aCO2 groups. Box plots depicting differences in
PPV, FCD, and HI for predefined Pv-aCO2 groups (group 1,
\6.0 mmHg; group 2, 6.0–9.9 mmHg; group 3, C10 mmHg) at
both T0 (a) and T6 (b). Kruskal–Wallis test, p\ 0.001. *Post hoc
Mann–Whitney analysis adjusted for multiple comparisons;
p\ 0.05 for group 1 vs. 2 and 1 vs. 3, **post hoc Mann–Whitney
analysis adjusted for multiple comparisons; p\ 0.05 for group 2
vs. 3. Boxes denote interquartile range, horizontal line in the boxes
represents the median values, and whiskers extend 1.5 times the
interquartile range above and below the 25th and 75th percentiles.
PPV percentage of small vessels perfused, Pv-aCO2 venous-to-
arterial carbon dioxide difference, FCD functional capillary
density, HI heterogeneity index
b
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strength between Pv-aCO2 vs. PPV, Pv-aCO2 vs. cardiac
output, and PPV vs. cardiac output variations.
A multiple linear regression model was used to deter-
minate the association between the Pv-aCO2, cardiac index,
SvO2, and mean arterial pressure with the percentage of
small perfused vessels (PPV). Subsequent multiple linear
regression models were constructed to test the relation
between Pv-aCO2 and the other systemic resuscitation
goals with PPV in patients with SvO2\65 % or C65 %.
The goodness of fit of each model was evaluated using the
coefficient of determination. Through the Spearman rho
test and calculating R2, we also evaluated the agreement
between PPV and Pv-aCO2, venous-to-arterial carbon
dioxide content (Cv-aCO2), and venous-to-arterial carbon
dioxide content to arterial-to-venous oxygen content ratio
(Cv-aCO2/Da-vO2).
Receiver operating characteristics (ROC) curves were
constructed to compare the accuracy of Pv-aCO2, lactate,
SvO2, and cardiac output in predicting altered PPV at dif-
ferent abnormal cutoff points (PPV50, PPV60, and
PPV70 %). Areas under the ROC curves (AUCs) and their
respective 95 % confidence intervals (CIs) were calculated
and compared using non-parametric statistics. Data are
presented as median [percentiles 25–75]. A p value of 0.05
or less (2-tailed) was considered significant.
Results
A total of 75 patients fulfilling the inclusion criteria were
included in the study (ESM Fig. E1). General character-
istics according to predefined Pv-aCO2 groups are
presented in Table 1. Mortality at day 28 in this cohort
was 34.7 % and the ICU length of stay was 6.0
(2.0–10.0) days. Time elapsed from first hypotension
episode until PAC insertion and blood sampling (i.e., T0)
was 3.0 (3.0–4.0) h and amount of fluids received at that
point was 1650 (1200–2400) ml.
A total of 39, 25, and 11 patients were assigned to the
three predefined Pv-aCO2 groups at T0, and 36, 23, and
13 at T6, respectively. Of these, 49/75 patients (65.3 %)
had SvO2 [65 % at T0 and 58/72 (82.9 %) attained a
SvO2[65 % at T6. Hemodynamic and respiratory vari-
ables, arterial and mixed-venous blood gases, and
oxygen-derived parameters for the predefined Pv-aCO2
groups at both T0 and T6 are shown in ESM Table E1.
Microcirculatory blood flow parameters are shown in
Table 2. We observed a progressively lower PPV with a
subsequent decrease in FCD and increased HI at progres-
sively higher Pv-aCO2 values at both T0 and T6 (Fig. 1).
Microcirculatory blood flow index (MFI) was also lower at
higher Pv-aCO2 values while total capillary density was
normal only in patients with normal Pv-aCO2 (ESM
Fig. E2).We observed a significant agreement between the
Pv-aCO2 and PPV (T0: R
2 = 0.61, p\ 0.001; T6:
R2 = 0.55, p\ 0.001; ESM Fig. E3). Conversely, we
found lack of agreement between the cardiac index (rep-
resenting the macro blood flow) and the PPV (ESM
Fig. E4). Other resuscitation and hemodynamic goals such
as SvO2 and MAP were also poorly correlated to the
microcirculatory blood flow (ESM Figs. E5, E6).
Changes in Pv-aCO2 values between T0 and T6 were
significantly related to changes in PPV, whereas changes
in cardiac output were not related to changes in Pv-aCO2
or PPV (Fig. 2, ESM Fig. E7).
Fig. 2 Scatter plots showing the correlation of variations observed
between changes in venous-to-arterial CO2 partial pressure differ-
ences (D Pv-aCO2) and a changes in percentage of small vessels
perfused (D PPV) between measurements performed at T0 and T6
(R2 = 0.42, p\ 0.001) and b changes in cardiac output (D cardiac
output) between measurements performed at T0 and T6
(R2 = 0.01, p = 0.45)
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A multiple linear regression model including all
patients revealed that Pv-aCO2 was independently related
to PPV at T0 and T6, whereas other systemic hemody-
namic parameters such as cardiac output, SvO2, or MAP
were not significantly related to microcirculatory blood
flow (Table 3). Likewise, when linear regression models
were performed separately in patients with SvO2\65 %
or SvO2 C65 %, Pv-aCO2 was again the only variable
related to PPV at both T0 and T6 (Table 3).
Even though Pv-aCO2 was apparently not correlated
with cardiac index in this septic shock group (ESM
Fig. E8), we observed lower cardiac indexes in predefined
groups with abnormal Pv-aCO2 values at T6 (ESM
Fig. E9). Similarly, lower MAP was observed in groups
with higher Pv-aCO2 values at T6 (ESM Fig. E10). We
also observed a trend towards lower SvO2 at higher Pv-
aCO2 values, without achieving significant differences
(ESM Fig. E11).
Pv-aCO2 exhibited the highest area under the ROC
curve (AUC) for predicting abnormal PPV at different
cutoffs at both T0 and T6. Other macrohemodynamic or
tissue perfusion parameters were not related to PPV (ESM
Fig. E12, Table E2).
Venous-to-arterial carbon dioxide differences calcu-
lated in terms of partial pressures (Pv-aCO2) were
significantly related to those calculated by blood contents
(Cv-aCO2) (T0: R
2 = 0.52, p\ 0.001; T6: R2 = 0.42,
p\ 0.001) (ESM Fig. E13). In addition to the significant
relation between PPV and Pv-aCO2, we also observed a
linear relationship between PPV and Cv-aCO2 (T0:
R2 = 0.42, p\ 0.001, T6: R2 = 0.32, p\ 0.001) and
between PPV and the Cv-aCO2/Da-vO2 ratio (T0:
R2 = 0.18, p\ 0.001) (Fig. 3, ESM Fig. E14).
When data were analyzed considering the Pv-aCO2 as
a dependent variable, PPV was independently related to
Pv-aCO2 (ESM Table E3). Remarkably, cardiac index
was also related to Pv-aCO2 but only in patients with
SvO2\65 % at T6 (ESM Table E3).
Discussion
Our observations reveal that Pv-aCO2 is closely related to
microcirculatory blood flow parameters during the early
phases of resuscitation of septic shock. Indeed, Pv-aCO2
was the best predictor of the microvascular blood flow
maldistribution as indicated by the alterations in the
percentage of small vessels perfused, the heterogeneity
blood flow index, and consequently FCD. In addition,
changes in Pv-aCO2 were significantly related to changes
in PPV. Meanwhile, Pv-aCO2 was poorly related to sys-
temic hemodynamic variables.
Microcirculatory dysfunction in septic shock is a
generalized phenomenon characterized by decreasing
FCD associated with increasing heterogeneity of blood
flow consisting in zones with well-perfused vessels
adjacent to non-perfused capillaries [21, 22]. Those
derangements seem to trigger the development of organ
dysfunctions because capillary blood flow alterations
precede cellular stress [30, 31] and hypoxia-inducible
gene expression [32]. In fact, microcirculatory alterations
are stronger determinants of outcomes than global
hemodynamic parameters, with progressive increase in
the risk of death in quartiles representing more severe
microcirculatory disturbances [33]. Nevertheless, some
Table 3 Multiple linear regression models for variables related to the percentage of small perfused vessels (PPV)
T0 T6
Coefficient 95 % CI p value Coefficient 95 % CI p value
All patients
Pv-aCO2 -5.35 -6.41 -4.29 \0.001 -3.49 -4.43 -2.55 \0.001
SvO2, % 0.12 -0.16 0.41 0.39 0.05 -0.25 0.35 0.75
CI, L/min -0.83 -3.47 1.81 0.53 -0.11 -4.29 4.06 0.96
MAP 0.23 -0.04 0.51 0.93 0.30 -0.04 0.64 0.08
R2 for the model – – – 0.66 – – – 0.58
SvO2 C65 %
Pv-aCO2 -5.11 -6.46 -3.76 \0.001 -3.92 -5.02 -2.82 \0.001
CI, L/min -0.31 -3.53 2.91 0.85 2.27 -2.48 7.02 0.34
MAP 0.32 -0.03 0.63 0.06 0.19 -0.21 0.59 0.34
R2 for the model – – – 0.63 – – – 0.61
SvO2\65 %
Pv-aCO2 -5.91 -7.63 -4.19 \0.001 -3.22 -5.39 -1.05 0.007
CI, L/min -2.18 -7.37 3.01 0.39 -3.68 -13.43 6.07 0.43
MAP -0.07 -0.65 0.52 0.82 0.39 -0.35 1.13 0.28
R2 for the model – – – 0.71 – – – 0.57
Pv-aCO2 venous to arterial carbon dioxide difference, SvO2 mixed venous oxygen saturation, CI cardiac index, MAP mean arterial
pressure, R2 coefficient of determination
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authors argue against microcirculatory dysfunction as the
primary event leading to organ failure because microcir-
culatory derangements might be coupled with cellular and
mitochondrial dysfunction and merely reflect an adaptive
response [34]. Despite controversies about the causal
relationship between microcirculatory alterations and
organ dysfunction, the quest for appropriate monitoring of
microcirculation could potentially improve resuscitation
results in septic shock. However, despite advances in the
techniques to evaluate microcirculation at the bedside, an
immediate and reliable method to quantify microcircula-
tory alterations is not yet available [35]. In our study, Pv-
aCO2 was independently related to PPV (and conse-
quently to FCD and MFI) at both T0 and T6, and this
relationship was also maintained when we evaluated
separately patients with SvO2\65 % or C65 %. Fur-
thermore, Pv-aCO2 was better at predicting abnormal
PPV values at different cutoffs, and it was superior to
macrohemodynamic or oxygen metabolism goals. Simi-
larly, Pv-aCO2[6.0 was related to an increased HI and
therefore a decreased FCD. In normal conditions, the
heterogeneity of microvascular blood flow is negligible
[36], and matching of perfusion to metabolism usually
improves during hypoxic or low flow states [37]. How-
ever, increases in the heterogeneity of the
microcirculatory blood flow with the subsequent reduc-
tion in the FCD could be responsible for altered oxygen
extraction capabilities in sepsis [38]. In fact, the hetero-
geneous flow cessation of individual capillaries could be
an important factor determining the oxygen supply
dependence phenomenon during the most severe cases of
septic shock [38, 39] and this heterogeneity of
microvascular blood flow could be tracked by Pv-aCO2
variations during the early stages of resuscitation. In fact,
changes observed in Pv-aCO2 between T0 and T6 were
significantly related to those exhibited by PPV during the
same time interval.
It has been suggested that microcirculatory derange-
ments can occur in the absence of macrohemodynamic
derangements even when global oxygen delivery seems
adequate [21, 40]. However, other small-sized studies
have insinuated that microcirculatory impairment is
related to decreasing mean arterial pressure or increasing
dose of vasopressors [41]. Our data also suggest some
independence between microcirculatory variables and
macrohemodynamics, which is in line with previous
observations [32, 39]. Indeed, changes exhibited by Pv-
aCO2 between T0 and T6 were not related to variations in
cardiac output. Nevertheless, patients with a Pv-aCO2
C6.0 exhibited a trend toward lower cadiac index and
MAP values than those with Pv-aCO2\6.0. Furthermore,
cadiac index was significant but weakly related to Pv-
aCO2 in patients with SvO2\65 % but not in those with
normal SvO2.
Pv-aCO2 can also be influenced by the CO2 dissocia-
tion curve. In this regard, we observed a good agreement
Fig. 3 Scatter plots depicting the relationships between the
percentage of small vessels perfused (PPV) at T0 and a the
venous-to-arterial CO2 partial pressure difference (Pv-aCO2), b the
venous-to-arterial CO2 content difference (Pv-aCO2), and c the
venous-to-arterial CO2 to arterial-venous O2 content difference
ratio (Cv-aCO2/Da-vO2). Coefficient of determination (R
2) was
calculated to assess the strength of correlations
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between Pv-aCO2 and the venous-to-arterial CO2 content
difference (Cv-aCO2), especially at normal ranges of Pv-
aCO2 (i.e., Pv-aCO2 \6.0 mmHg). Interestingly, Cv-
aCO2 was mostly dispersed at higher Pv-aCO2 values,
suggesting a deeper impact of the Haldane effect at
abnormal Pv-aCO2 values. Similarly, difference between
slopes described by the linear regression of PPV vs. Pv-
aCO2 and PPV vs. Cv-aCO2 relationships should also be
influenced by the Haldane effect. Nevertheless, the also
significant relationship between PPV vs. Cv-aCO2 sug-
gests that CO2 accumulation is, at least in part, related to
the abnormal microcirculatory blood flow occurring dur-
ing inflammatory conditions.
It has been recently suggested that combination of
venous-to-arterial CO2 content to arterial-venous O2 dif-
ference ratio (Cv-aCO2/Da-vO2) can add prognostic value
to lactate measurements during early stages of septic
shock [42] because it could be used as a surrogate for the
VCO2/VO2 ratio (i.e., the respiratory quotient), to
potentially detect non-aerobic CO2 generation [43]. We
explored the association between the Cv-aCO2/Da-vO2
ratio and microcirculatory alterations; although, we found
a significant correlation, the strength of such a relation-
ship was notoriously weaker than that observed between
Pv-aCO2 (or even Cv-aCO2) and PPV. We acknowledge
that the Cv-aCO2/Da-vO2 ratio could be subjected to
more error in calculations than Pv-aCO2, but differences
in the slope of the Cv-aCO2/Da-vO2 ratio vs. PPV com-
pared with the Pv-aCO2 vs. PPV relationship suggest the
involvement of other physiological variables different to
microcirculatory blood flow. Indeed, the Cv-aCO2/Da-
vO2 ratio was abnormally increased in a number of
patients through a wide range of PPV values. Therefore, it
is not surprising that the Cv-aCO2/Da-vO2 ratio is supe-
rior to the Pv-aCO2/Da-vO2 ratio in the clinical setting
[41] because under hypoxic conditions, disparity between
Pv-aCO2 and Cv-aCO2 increases, and when coupling Pv-
aCO2 to different DO2/VO2 values, pH, temperature, and
hemoglobin levels, the Pv-aCO2/Da-vO2 may acquire
different cutoff normality values (a situation obviated
when the numerator is corrected with the determinants of
the Haldane effect).
We recognize limitations to our study. First, we used
mixed venous blood to assess Pv-aCO2 gradients, thus our
results may not apply to central venous blood Pv-aCO2
gradients. Indeed, even though a reasonable agreement is
often reported in trials comparing both sampling sites
[44], significant discrepancy can sometimes be observed
and should not be neglected. Of note, this concordance
between sampling sites has mostly be evaluated for SvO2
more than for PCO2 gradients. Second, variations of Pv-
aCO2, macrohemodynamics, and microcirculatory vari-
ables between T0 and T6 were not the result of targeted
interventions but simply changed during resuscitation.
Nevertheless, relationships exhibited between Pv-aCO2
and PPV allow us hypothesize that some specific thera-
peutic interventions modifying microcirculation might
reliably be tracked by Pv-aCO2. Third, the relationship
observed between microcirculatory variables and Pv-
aCO2 does not establish a causal association even though
the physiological reasoning leading to our conclusions
seems logical. Finally, there was no pre-experimental
statistical plan published in a prespecified registry or a
journal. However, observational research is, by nature,
exploratory and requires considerable flexibility to
explore novel findings and unexpected signals in the data
[45, 46].
In conclusion, increased Pv-aCO2 values are associ-
ated with microcirculatory dysfunction in septic shock,
even when SvO2 is within normal values. Whether
changes in Pv-aCO2 can be used to track changes in
microvascular perfusion remains to be determined.
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